Vemurafenib and trametinib reduce expression of CTGF and IL-8 in V600EBRAF melanoma cells.
about
Synthetic lethal short hairpin RNA screening reveals that ring finger protein 183 confers resistance to trametinib in colorectal cancer cells.Exogenous growth factors bFGF, EGF and HGF do not influence viability and phenotype of V600EBRAF melanoma cells and their response to vemurafenib and trametinib in vitroAcquired resistance to BRAFi reverses senescence-like phenotype in mutant BRAF melanoma
P2860
Vemurafenib and trametinib reduce expression of CTGF and IL-8 in V600EBRAF melanoma cells.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Vemurafenib and trametinib red ...... 8 in V600EBRAF melanoma cells.
@en
Vemurafenib and trametinib red ...... 8 in V600EBRAF melanoma cells.
@nl
type
label
Vemurafenib and trametinib red ...... 8 in V600EBRAF melanoma cells.
@en
Vemurafenib and trametinib red ...... 8 in V600EBRAF melanoma cells.
@nl
prefLabel
Vemurafenib and trametinib red ...... 8 in V600EBRAF melanoma cells.
@en
Vemurafenib and trametinib red ...... 8 in V600EBRAF melanoma cells.
@nl
P2093
P2860
P1476
Vemurafenib and trametinib red ...... 8 in V600EBRAF melanoma cells.
@en
P2093
Izabela Zalesna
Mariusz L Hartman
Marta Osrodek
Michal Rozanski
P2860
P2888
P304
P356
10.1038/LABINVEST.2016.140
P577
2017-01-09T00:00:00Z
P6179
1004077182